SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022151
Filing Date
2022-08-12
Accepted
2022-08-11 19:08:43
Documents
84
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1808028
2 ex31-1.htm EX-31.1 18029
3 ex31-2.htm EX-31.2 17823
4 ex32-1.htm EX-32.1 8099
  Complete submission text file 0001493152-22-022151.txt   9780244

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocx-20220630.xsd EX-101.SCH 84742
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocx-20220630_cal.xml EX-101.CAL 74669
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocx-20220630_def.xml EX-101.DEF 439757
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocx-20220630_lab.xml EX-101.LAB 620455
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocx-20220630_pre.xml EX-101.PRE 528060
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1655781
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 221157388
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences